Platelet and megakaryocyte CD40L expression in β-Thalassemic patients
- PMID: 32199173
- DOI: 10.1016/j.thromres.2020.02.026
Platelet and megakaryocyte CD40L expression in β-Thalassemic patients
Keywords: Aspirin; CD40 ligand; Megakaryocytes; Platelets; β-Thalassemia.
Conflict of interest statement
Declaration of competing interest The authors declare no competing interests.
Similar articles
-
CD40L Priming of Platelets via NF-κB Activation is CD40- and TAK1-Dependent.J Am Heart Assoc. 2018 Dec 4;7(23):e03677. doi: 10.1161/JAHA.118.009636. J Am Heart Assoc. 2018. PMID: 30571597 Free PMC article.
-
Platelets as Key Factors in Inflammation: Focus on CD40L/CD40.Front Immunol. 2022 Feb 3;13:825892. doi: 10.3389/fimmu.2022.825892. eCollection 2022. Front Immunol. 2022. PMID: 35185916 Free PMC article. Review.
-
Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity.Blood Coagul Fibrinolysis. 2002 Sep;13(6):505-12. doi: 10.1097/00001721-200209000-00005. Blood Coagul Fibrinolysis. 2002. PMID: 12192302
-
Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes.Blood. 2004 Sep 1;104(5):1361-8. doi: 10.1182/blood-2004-03-0926. Epub 2004 May 6. Blood. 2004. PMID: 15130939
-
The signaling role of CD40 ligand in platelet biology and in platelet component transfusion.Int J Mol Sci. 2014 Dec 3;15(12):22342-64. doi: 10.3390/ijms151222342. Int J Mol Sci. 2014. PMID: 25479079 Free PMC article. Review.
Cited by
-
Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.Front Immunol. 2021 Jun 25;12:695815. doi: 10.3389/fimmu.2021.695815. eCollection 2021. Front Immunol. 2021. PMID: 34305932 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
